acutephas
respons
part
initi
respons
inflammatori
stimuli
follow
inflammatori
insult
hepat
synthesi
heterogen
group
acutephas
protein
increas
jensen
whitehead
serum
amyloid
saa
identifi
acutephas
marker
human
level
increas
respons
inflammatori
stimul
steel
whitehead
gabay
kushner
uhlar
whitehead
earlier
studi
conclud
saa
acid
glycoprotein
agp
haptoglobin
use
indic
acutephas
statu
cat
kajikawa
et
al
sasaki
et
al
giordano
et
al
part
studi
present
annual
intern
colloquium
anim
acut
phase
protein
march
dublin
ireland
concern
dynam
saa
follow
inflammatori
stimulu
report
saa
increas
h
kajikawa
et
al
h
sasaki
et
al
follow
inflammatori
stimulu
reach
maximum
h
kajikawa
et
al
h
sasaki
et
al
initi
stimul
comparison
agp
exhibit
increas
serum
concentr
later
saa
follow
inflammatori
stimulu
steel
whitehead
concentr
also
wane
later
kajikawa
et
al
widespread
use
acutephas
protein
biomark
inflammatori
statu
human
medicin
led
grow
attent
use
anim
medicin
eckersal
signific
differ
felin
saa
concentr
clinic
healthi
cat
cat
variou
inflammatori
diseas
disord
alreadi
found
direct
elisa
use
felin
saaspecif
monoclon
antibodi
sasaki
et
al
howev
reliabl
rapid
autom
readili
avail
assay
need
felin
saa
measur
implement
routin
diagnosi
monitor
aim
present
studi
evalu
valid
commerci
avail
autom
human
saa
turbidimetr
immunoassay
saatia
detect
measur
saa
concentr
cat
mean
assess
imprecis
inaccuraci
detect
limit
overlap
perform
serum
sampl
obtain
clientown
cat
clientown
patient
present
small
anim
veterinari
teach
hospit
royal
veterinari
agricultur
univers
copenhagen
denmark
variou
diagnost
therapeut
prophylact
measur
addit
clinic
healthi
main
coon
cat
age
sex
regist
particip
cardiomyopathi
screen
programm
hospit
assign
studi
control
group
healthi
control
cat
subject
clinic
examin
standard
haematolog
biochem
profil
jensen
et
al
diagnost
procedur
individu
cat
conduct
discret
individu
clinician
eg
radiographi
cytolog
histopatholog
histolog
smear
endocrin
test
serum
sampl
obtain
centrifug
min
blood
sampl
collect
plain
vial
contain
clot
activ
separ
gel
vacuett
greiner
bioon
kremsmuenst
austria
sampl
store
plastic
vial
c
analysi
never
longer
month
saa
concentr
determin
use
human
turbidimetr
immunoassay
saatia
lzsaa
lot
eiken
chemic
co
tokyo
japan
analys
perform
autom
analys
advia
chemistri
system
bayer
newburi
uk
accord
manufactur
recommend
calibr
curv
creat
use
human
saa
calibr
manufactur
eiken
chemic
co
analys
perform
use
felinespecif
singl
radial
immunodiffus
assay
felin
plate
institut
metabol
ecosystem
miyagi
japan
follow
direct
suppli
manufactur
saa
content
determin
cat
three
pool
high
low
medium
concentr
saa
obtain
mix
serum
sampl
high
low
medium
saa
concentr
rang
number
sampl
mix
high
pool
mgl
n
medium
pool
mgl
n
low
pool
mgl
n
intraassay
variat
determin
measur
saa
concentr
withinrun
altern
high
low
medium
pool
seven
success
time
interassay
variat
assess
saa
determin
betweenrun
measur
three
pool
pool
frozen
separ
ident
vial
betweenrun
analys
vial
need
thaw
prevent
potenti
variat
due
repetit
freezethaw
cycl
linear
dilut
use
physiolog
salin
determin
indirectli
estim
inaccuraci
duplic
withinrun
measur
continu
dilut
high
saa
concentr
serum
pool
jensen
detect
limit
calcul
data
replic
measur
steril
sodium
chlorid
blank
overlap
perform
assay
assess
two
way
abil
identifi
cat
acutephas
respons
b
abil
show
expect
differ
saa
concentr
differ
group
diseas
healthi
cat
detail
individu
cat
categor
accord
serum
concentr
agp
high
concentr
indic
presenc
acutephas
respons
kajikawa
et
al
cutoff
valu
gl
use
base
data
report
selt
et
al
b
cat
assign
retrospect
five
differ
diagnost
group
accord
final
diagnosi
attend
clinician
regard
clinic
haematolog
clinic
biochem
patholog
find
ie
clinic
healthi
cat
cat
diagnos
inflammatoryinfecti
diseas
endocrinemetabol
diseas
neoplast
diseas
miscellan
disord
n
respect
cat
neoplast
diseas
tumour
cytolog
andor
histolog
character
neoplast
cat
infect
pathogen
identifi
could
relat
patholog
find
cat
endocrinemetabol
disord
final
diagnosi
could
relat
hormon
metabol
malfunctiondisord
cat
miscellan
diseas
variou
diagnos
clinic
find
associ
group
healthi
control
assign
group
clinic
healthi
overlap
perform
assess
compar
distribut
saa
level
within
variou
group
set
b
standard
deviat
arithmet
mean
median
intraand
interassay
coeffici
variat
cv
assess
use
standard
descript
procedur
box
et
al
et
al
detect
limit
estim
mean
valu
blank
plu
three
standard
deviat
jensen
linear
dilut
analys
ordinari
linear
regress
analysi
run
test
perform
investig
whether
data
follow
straight
line
jensen
correl
agp
saa
assess
spearman
correl
coeffici
mannwhitney
nonparametr
test
use
investig
statist
signific
differ
saa
concentr
cat
group
without
presenc
acutephas
respons
accord
agp
concentr
siegel
kruskallw
oneway
analysi
use
detect
differ
median
diagnost
group
indic
differ
distribut
dunn
multipl
comparison
test
appli
obtain
addit
inform
regard
deviat
siegel
level
signific
test
set
observ
intraand
interassay
imprecis
rang
respect
tabl
linear
dilut
observ
sign
deviat
straight
line
model
slope
uniti
intercept
zero
tabl
ii
detect
limit
mgl
mean
mgl
sd
mgl
clinic
characterist
descript
data
serum
agp
saa
concentr
includ
cat
given
tabl
iii
kajikawa
et
al
mgl
giordano
et
al
variat
studi
like
due
use
differ
methodolog
lack
avail
materi
standard
felin
saa
assay
detect
limit
estim
mgl
within
observ
physiolog
rang
saa
concentr
healthi
cat
impair
clinic
applic
primari
purpos
saa
measur
would
identifi
horizont
line
indic
median
saa
concentr
individu
group
except
neoplasia
accord
previou
report
overlap
perform
felin
saa
kajikawa
et
al
sasaki
et
al
furthermor
differ
appear
magnitud
would
make
observ
imprecis
detect
limit
accept
clinic
use
cutoff
valu
agp
use
differenti
cat
without
acutephas
respons
establish
independ
present
studi
upper
confid
limit
solberg
agp
level
healthi
cat
data
includ
healthi
cat
agp
serum
concentr
measur
use
method
present
studi
selt
et
al
previous
report
kinet
differ
saa
agp
kajikawa
et
al
could
caus
minor
uncertainti
regard
parallel
presenc
protein
acutephas
respons
effect
consid
neglig
present
studi
assumpt
sustain
observ
signific
correl
two
acutephas
protein
signific
differ
found
group
infectiousinflammatori
disord
group
neoplast
diseas
presum
group
neoplast
disord
heterogen
acutephas
respons
also
observ
anoth
studi
selt
et
al
thu
assay
demonstr
overlap
perform
expect
felin
saa
variat
due
freez
storag
sampl
present
studi
neglig
saa
report
stabl
c
mcdonald
et
al
agp
report
unaffect
freez
ganz
et
al
previou
report
avail
speciesspecif
determin
felin
saa
dibartola
et
al
sasaki
et
al
heterolog
determin
mean
rabbit
anticanin
saaantibodybas
elisa
kajikawa
et
al
kajikawa
et
al
antihuman
saaantibodybas
elisa
giordano
et
al
howev
none
assay
seem
suffici
practic
routin
applic
term
avail
autom
author
knowledg
previou
report
demonstr
suffici
reliabl
saatia
base
antihuman
saa
antibodi
heterolog
determin
felin
saa
concentr
analog
use
human
medicin
felin
saa
measur
suggest
applic
diagnost
monitor
purpos
kajikawa
et
al
sasaki
et
al
avail
fast
reliabl
readili
avail
autom
assay
saatia
facilit
measur
felin
saa
diagnost
laboratori
thu
routin
applic
felin
medicin
